Journal of Solid Tumors

Journal of Solid Tumors (JST) is an open access, peer-reviewed international journal that considers articles on all aspects of cancer research. The journal welcomes submissions concerning the molecular and cell biology of solid tumors, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. Randomized controlled trials, especially phase III trials and evidence-based meta-analysis or pooled analysis related to specific trials are preferred clinical papers. The primary criterion for publication is interest to a multidisciplinary audience.

The articles of JST are indexed in:

  • EBSCOhost
  • Embase
  • Google Scholar
  • Lockss
  • PKP Open Archives Harvester
  • ProQuest
  • The Standard Periodical Directory

The journal is published in both print and online versions. The online version is free to access and download.

To facilitate rapid publication and to minimize administrative costs, the journal accepts Online submission and Email submission. All manuscripts and any supplementary material can be submitted via the journal’s Online Submission and peer-review system or email to For online submission, please create a new account and then follow the instructions given on the screen.

JST’s Sections:

Original Research, Case Reports, Reviews.



2015: Articles Received: 43; Accepted: 25; Rejected: 10; Published: 30; Retracted: 1

2015 Q4: Articles Received: 18; Accepted: 8; Rejected: 4; Published: 7; Retracted: 0

2015 Q3: Articles Received: 7; Accepted: 3; Rejected: 0; Published: 5; Retracted: 0

2015 Q2: Articles Received: 12; Accepted: 8; Rejected: 3; Published: 8; Retracted: 0

2015 Q1: Articles Received: 6; Accepted: 6; Rejected: 3; Published: 10; Retracted: 0

2014: Articles Received: 32; Accepted: 20; Rejected: 8; Published: 10; Retracted: 1

2013: Articles Received: 74; Accepted: 42; Rejected: 39; Published: 10; Retracted: 1


What is e-Version FirstTM

e-Version First is a feature offered through our journal platform. It allows PDF version of manuscripts that have been peer reviewed and accepted, to be hosted online prior to their inclusion in a final printed journal. Readers can freely access or cite the article. We aim to publish accepted manuscripts in e-Version First in two week's time after the final draft completed.


Paper Selection and Publication Process

a) Upon receipt of paper submission, the Editor sends an E-mail of confirmation to the corresponding author within 1-3 working days. If you fail to receive this confirmation, your submission/e-mail may be missed. Please contact the Editor in time for that.

b) Peer review. We use double-blind system for peer-review; both reviewers and authors' identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 2-3 weeks.

c) Notification of the result of review by E-mail.

d) The authors revise paper and pay publication fee (200.00 USD).

e) After publication, the corresponding author will receive the copy of printed journal, free of charge.

f) E-journal in PDF is available on the journal’s webpage, free of charge for download.


The publisher and journal have a policy of “Zero Tolerance on the Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (

All submissions will be checked by iThenticate before being sent to reviewers.



Call for Papers--Journal of Solid Tumors

We are calling for papers for Journal of Solid Tumors. If you have suitable manuscripts about oncology research, please don't hesitate to submit them to:  
Posted: 2015-08-10 More...
More Announcements...

Vol 5, No 2 (2015)

Journal of Solid Tumors, Vol. 5, No. 2, October 2015

Table of Contents

Original Articles

Rhabdomyosarcoma in adolescents: A CCHE experience PDF
Emad A.H Moussa, Enas El Nadi, Hosam El Zomor, Hanafy Ahmed Hafez, Alaa Younes, Hala Taha, Naglaa EL-Kenanii, Mohamed S. Zaghloul, Madeha El-Wekeel, Rania M. Labib, Marwa Tantawy p1
Irreversible electroporation of malignant lesions: An institution experience PDF
Benjamin J. Bates, Minia Hellan, Shannon Kauffman, James Ouellette p11
PET/CT and MIBG scans in diagnosis and management of Neuroblastoma PDF
Mohamed Fawzy, Emad Moussa, Asmaa Hamouda, Ahmed Zaher, Omneya Hassanein, Sara Azmy p32
Expressions of Aquaporin4, VEGFR1 and the pattern of genetic aberrations in meningiomas have no influence on the peritumoral edema PDF
Stefan Linsler, David Reuss, Markus Klotz, Karl-Herbert Schaefer, Joachim Oertel, Ralf Ketter, Steffi Urbschat p40
Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinoma PDF
Javier Lopez Araujo, Rojymon Jacob, Craig Baden, John B. Fiveash, Michael Dobelbower, James E. Bryant, Graeme B. Bolger p59
Anticancer activity of a novel quinazolinone-chalcone derivative through cell cycle arrest in pancreatic cancer cell line PDF
Zahoor A. Wani, Anup S. Pathania, Girish Mahajan, Akanksha Behl, Mubashir J. Mintoo, Santosh K. Guru, A. Viswanath, Fayaz Malik, Ahmed Kamal, Dilip M. Mondhe p73
Real world experience with dose dense ac-paclitaxel: Two canadian cancer centers’ experience PDF
Emad Tashkandi, Michael Yan, Jawaid Younus, MA Jawaid, Caroline Hamm, Swati Kulkarni, Rasna Gupta, John Matthews, Tarek Elfiki, Larry Stitt p86
Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt PDF
Enas El-Nadi, Hossam Elzomor, Rania M. Labib, Ahmad S. Alfaar, Mohamed S. Zaghloul, Hala Taha, Alaa Younes, Madeeha Elwakeel p94
Irinotecan and temozolomide in adults with recurrent sarcoma PDF
Phillip S. Blanchette, Aaron Lo, Pamela Ng, Albiruni Razak, Eitan Amir, David Hogg, Martin E. Blackstein, Abha A. Gupta p105

Case Reports

Metastatic adamantinoma responds to treatment with receptor tyrosine kinase and Aurora A kinase inhibitor PDF
Imran Unal, Odile David, Arkadiusz Z. Dudek p27
Bullous pemphigoid appearing as superficial tissue necrosis after irradiation of the breast: Case history and definitive review of the literature PDF
Mark Gerard Trombetta, Kathleen Erb, Vijay Kudithipudi, Judith Small p53
Liposarcoma arising from the right renal sinus with inferior vena caval involvement PDF
Yasuyuki Kobayashi, Masashi Nakayama, Kyosuke Matsuzaki, Ken Takeda, Takahiro Yoshida, Yasuyuki Arai, Kenichi Kakimoto, Michiko Yuki, Yasuhiko Tomita, Yutaka Ono, Kazuo Nishimura p69

Case Studies

Hepatocellular carcinoma treatment strategies – a case-based review PDF
Rute Alves, Manuel Teixeira Gomes, Carlos Sampaio Macedo, Helena P. Miranda, Filipe Nery p120


The recent progress of neoadjuvant chemotherapy in triple negative breast cancer: A short review PDF
Michalis Liontos, Sophia Karageorgopoulou, Vasiliki Michalaki, John Contis, Evangelos Bournakis, John Vassiliou, Meletios-Athanasios Dimopoulos, Christos A. Papadimitriou p18
HPV prophylactic vaccines: Second-generation or first-generation vaccines PDF
Kimia Kardani, Golnaz Mardani, Azam Bolhassani p112

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.